Opendata, web and dolomites

Embryospin

Increasing IVF success rate through the first magnetic resonance system for embryonic quantitative analysis at the cell scale

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Embryospin project word cloud

Explore the words cloud of the Embryospin project. It provides you a very rough idea of what is the project "Embryospin" about.

microscope    launch    belgium    poised    savings    microscopic    optical    bench    subsidize    business    labels    performances    microns    33    embryospin    fold    plan    resonance    prospective    france    beginning    performed    healthcare    strategy    nuclear    qualitative    starting    hour    sensor    family    surprisingly    frustratingly    performs    vitro    preparation    today    disposable    2021    techniques    refine    costly    coupled    investment    turn    validate    screen    despite    attract    validation    rate    radically    decades    nmr    patent    chemical    technique    suitable    ivf    embryo    micronmr    fertilization    market    screening    technologies    insights    laboratories    tissue    couples    device    germany    provides    pad    commercialize    pricing    purely    annaida    infertile    morphological    national    biopsy    desire    viability    pave    fulfil    commercialization    magnetic    embryos    rates    improvement    invasive    scaling    opportunity    engineering    customers    filed   

Project "Embryospin" data sheet

The following table provides information about the project.

Coordinator
ANNAIDA TECHNOLOGIES SARL 

Organization address
address: AVENUE LOUIS-RUCHONNET 26
city: LAUSANNE
postcode: 1003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://www.linkedin.com/company/annaida-technologies/about/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ANNAIDA TECHNOLOGIES SARL CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

Today 1 out of 6 couples turn to the In Vitro Fertilization (IVF) technique to fulfil their desire of starting a family. Despite decades of research and high costs, the success rate of IVF remains frustratingly low (33%). A key factor in determining the IVF success is the embryo screening to determine viability. Surprisingly enough, embryo selection is currently performed through optical analysis with a microscope, that is a purely morphological, qualitative assessment that provides no reliable insights on embryo viability. Other available techniques are costly and invasive, since require the use of chemical labels or even a tissue biopsy. Annaida Technologies has developed Embryospin, a patent-filed device that performs microscopic Nuclear Magnetic Resonance (microNMR) at a scale of 100 microns, a 10-fold improvement over existing technologies. Annaida will develop and commercialize an NMR bench-top device, coupled with a disposable microNMR sensor able to screen up to 10 embryos in less than an hour. The technology is poised to radically increase the IVF laboratories’ success rates, thus ensuring significant savings to infertile couples and also to National Healthcare Systems that subsidize IVF costs, like France, Belgium and Germany. The Phase 1 project will be a launch pad for the future commercialization of the system, enabling to validate the Embryospin performances and the market opportunity, determine the most suitable pricing strategy, and refine the business plan to attract the future investment needed for scaling up the production. The following step will be to proceed with system engineering and preparation to the in-field validation (Phase 2) together with large prospective customers, which will pave the way to the beginning of the commercialization phase in 2021.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYOSPIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYOSPIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Nocturne (2019)

The eye as a window to the brain, extending lifelong brain health

Read More  

Manuback (2019)

MANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods

Read More  

SCAT (2019)

Smart Composites for Additive Technology

Read More